申请人:Astra Pharmaceuticals Limited
公开号:US06100246A1
公开(公告)日:2000-08-08
There are provided novel compounds of formula (I) ##STR1## wherein A represents a benzo ring; a six membered heterocyclic aromatic ring containing 1 to 3 nitrogen atoms; or a five membered heterocyclic aromatic ring containing 1 to 3 heteroatoms which may be the same or different and are selected from O, N and S; and R.sup.1, R.sup.2, R.sup.3 and X are as defined in the Specification and pharmaceutically acceptable salts thereof and enantiomers and tautomers thereof; together with processes for their preparation, compositions containing them and their use in therapy. The compounds are inhibitors of nitric oxide synthase and are thereby particularly useful in the treatment and prophylaxis of inflammatory disease and pain.
提供了式(I)的新化合物,其中A代表苯环;含有1至3个氮原子的六元杂环芳香环;或含有1至3个杂原子(可以是相同的或不同的)的五元杂环芳香环,所述杂原子从O、N和S中选择;而R.sup.1、R.sup.2、R.sup.3和X如规范中所定义,以及其药学上可接受的盐和其对映体和互变异构体;以及它们的制备方法、含有它们的组合物及其在治疗中的用途。这些化合物是一氧化氮合酶抑制剂,因此在治疗和预防炎症性疾病和疼痛方面特别有用。